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BACKGROUND: The mutation spectrums of hemoglobinopathy are different among populations that yield a different result of erythrocyte indices. 
Calculation of erythrocyte indices with some formula has 
been reported to differentiate between hemoglobinopathy 
and non-hemoglobinopathy, but its cut-off should be 
recalculated specific for each population to gain a better 
sensitivity and specificity. We aimed to evaluate red blood 
cell count (RBC), Mentzer index, red cell distribution 
width (RDW), RDW index (RDWI), Shine and Lal 
index (S&L) and Green and King index (G&K) to screen 
hemoglobinopathy in Indonesia.
METHODS: A retrospective cross-sectional study 
was performed on 202 subjects. The diagnosis of 
hemoglobinopathy was determined based on the results 
of complete blood count (CBC) data, high-performance 
liquid chromatography (HPLC) and Hemoglobin H (HbH) 
inclusion body. The ferritin concentration was checked to 
determine the status of iron. The erythrocytes indices were 
analyzed and calculated to predict hemoglobinopathy.
Abstract
Introduction
Hemoglobinopathy, which consists of thalassemia and 
hemoglobin variant (1), is the most frequent genetic disorder 
found in the world. Its prevalence in Indonesia is about 
10%. A screening program has been proposed to prevent an 
increasing number or new case of thalassemia.(2) 
 Early screening of hemoglobinopathy using complete 
blood count (CBC) generally shows a normal or slightly 
RESULTS: A total 202 subjects who met the criteria 
were involved in this study. Fifty percent showed pure 
hemoglobinopathy and 4% showed a combination of 
thalassemia and hemoglobinopathy. The hemoglobin 
concentration and RBC were significantly higher, and 
the mean corpuscular volume (MCV) and RDW were 
significantly lower in hemoglobinopathy compared to 
iron deficiency. The difference was not significant if the 
hemoglobinopathy was combined with iron deficiency. By 
this study's cut-off, the G&K and RDWI showed the highest 
accuracy, sensitivity, and specificity. 
CONCLUSION: The new cut-off of erythrocyte index and 
its calculation to screen hemoglobinopathy in Indonesia 
showed a higher sensitivity and specificity, especially for 
G&K and RDWI with cut-off 73 and 228, respectively. The 
presence of iron deficiency in hemoglobinopathy could 
decrease the sensitivity.
KEYWORDS: hemoglobinopathy, RBC, Mentzer index, 
RDW, RDWI, S&L, G&K
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decrease of hemoglobin level with a low mean corpuscular 
volume (MCV) and mean corpuscular hemoglobin (MCH), 
but a high red blood cell distribution width (RDW). These 
characteristics are not only found in hemoglobinopathy, 
but it also could be found in iron deficiency and chronic 
disease. The treatment of these three conditions is not 
similar, whereas iron supplementation is indicated for iron 
deficiency, but it is not indicated for hemoglobinopathy and 
chronic disease.(3) Therefore, further examinations, such 
as iron level, total iron binding capacity (TIBC), ferritin, 
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evaluation of hemoglobin A2 (HbA2), hemoglobin F (HbF), 
and the presence of an abnormal hemoglobin fraction 
should be performed.(4) However, the cost of these further 
examination is high and not all health care in Indonesia 
provide the facility to do all of these tests. Therefore, 
analysis of CBC result should be optimized. 
 Some formulas derived from erythrocytes indices 
have been reported to distinguish between thalassemia 
and other causes.(4-11) An appropriate cut-off of reported 
formulas should be redetermined to increase the sensitivity 
and specificity of thalassemia screening in one population 
because the spectrums of mutation of thalassemia are 
different among population which might result in different 
values of erythrocytes indices.(12-15) This study aimed to 
evaluate red blood cell count (RBC) and some formulas 
using erythrocytes indices, such as Mentzer index, RDW, 
RDW index (RDWI), Shine and Lal index (S&L), and Green 
and King index (G&K) for hemoglobinopathy screening in 
Indonesia.
This was a retrospective cross-sectional study that was 
performed in Prodia Clinical Laboratory (Jakarta, Indonesia) 
in 2015-2016 and the ethical clearance of this study had 
been approved by Medical Faculty of Trisakti University, 
with Ethical Number 73/KER/FK/III/2015.
 Two hundred and two patients who underwent 
thalassemia screening and showed low MCV and MCH 
were recruited in this study. Subjects who had white blood 
cell count greater than 20% of its reference range, or had a 
history of blood transfusion within previous 3 months were 
excluded from this study. 
 The diagnosis of hemoglobinopathy was determined 
and classified by Clinical Pathologist based on an 
evaluation of CBC result, erythrocytes morphology, the 
presence of Hemoglobin H (HbH) inclusion bodies, and 
the result of hemoglobin fraction using high-performance 
liquid chromatography (HPLC) method. Beta thalassemia 
trait, if the erythrocyte showed microcytic hypochromic, 
low MCV, low MCH, and HbA2 fraction was between 
3.5-5.0% or slightly greater in some case of mutation. 
Heterozygote Hemoglobin E (HbE) (trait), if the erythrocyte 
showed microcytic hypochromic, low MCV, low MCH, 
and HbA2 fraction was about 30%. Beta-thalassemia/HbE 
double heterozygote,  if the erythrocyte was microcytic 
hypochromic, low MCV, low MCH, HbA2 was between 
40-60%, and HbF was between 5-87%.(16) Alpha trait 
Methods
Results
thalassemia, if the erythrocyte was slightly microcytic 
hypochromic, low MCV, low MCH, HbA2 fraction was 
normal or slightly decreased, HbF was generally normal, Hb 
Bart's as 0.8-11% could be present in the first 3 months of life, 
and HbH inclusion body could be found but very rare.(1,16) 
Diagnosis of HbH disease was based on the presence of 
microcytic hypochromic erythrocyte, low MCV, low MCH, 
HbA2 was between 1-2%, HbF was between 1-3.5%, and a 
large amount of HbH inclusion bodies were found (35-90% 
of RBC). The presence of alpha thalassemia trait could not 
be excluded if the erythrocyte was microcytic hypochromic, 
low MCV, low MCH, the HbA2 fraction was equal to or 
less than 3.5%, but the HbH inclusion body was not found, 
and ferritin level was not decreased.(16) The presence of 
iron deficiency was determined if the ferritin level was less 
than the reference value. If hemoglobinopathy was present 
with iron deficiency, it was classified as a combination of 
hemoglobinopathy and iron deficiency.
 Subject who classified as "combination of 
hemoglobinopathy and iron deficiency" or "alpha 
thalassemia trait could not be excluded" were not included 
for cut-off analysis.  The CBC data from the instrument, 
such as hemoglobin concentration, RBC, MCV, MCH and 
RDW as part of routine hematology measurement were 
recorded. These data were used for some calculation of 
formulas to predict hemoglobinopathy, such as, (1) Mentzer 
index = MCV / RBC, (2) RDWI = MCV / RBC x RDW, (3) 
S&L index = MCV2 x MCH x 0.01, (4) G&K index = MCV2 
x RDW / (100 x Hb). (8,11)  The data was analyzed using 
IBM SPSS Statistics, version 22.
Subjects involved in this study aged between 0.6-76 years 
old (mean 30 years old). The characteristics of the subjects 
were shown in Table 1. 
 The median of erythrocytes indices showed significant 
differences among groups (Figure 1). Hemoglobin 
concentration and RBC were significantly higher, but MCV 
and RDW were significantly lower in hemoglobinopathy 
compared to iron deficiency. But if the hemoglobinopathy 
was combined with iron deficiency, there were not any 
significant differences in these parameters between the 
subject with hemoglobinopathy only and subject with a 
combination of hemoglobinopathy and iron deficiency.
 The cut-off of RBC, Mentzer index, RDW, RDWI, 
S&L and G&K were determined using receiver operating 
curve (ROC) (Table 2). To obtain the cut-off, we calculated 
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Table 1.  Characteristic of the subject (n = 202).
 
n %
Male 52 25.7
Female 150 74.3
Iron deficiency 63 31.2
Hemoglobinopathy 101 50.0
   • Beta thalassemia trait (n = 35)
   • Alpha thalassemia trait (n = 36)
   • HbE trait (n = 22)
   • Beta thalassemia/ HbE double heterozygote (n = 2)
   • HbH disease (n = 6)
Combination of hemoglobinopathy & iron deficiency 8 4.0
   • Combination of beta thalassemia & iron deficiency (n = 2)
   • Combination of alpha thalassemia & iron deficiency (n = 1)
   • Combination of HbE trait & iron deficiency (n = 5)
Alpha thalassemia trait could not be excluded 30 14.9
Gender
Etiology of microcytic hypochromic erythrocyte
Characteristic
Figure 1. Comparison of median erythrocyte indices among groups of the subject. Note: A = iron deficiency (n = 63); B = 
hemoglobinopathy (n = 101); C = combination of hemoglobinopathy and iron deficiency (n = 8) ; D = alpha thalassemia trait could not be 
excluded (n = 30).
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164 data of 63 subjects with iron deficiency and 101 subjects 
with hemoglobinopathy. The highest accuracy to predict 
hemoglobinopathy was obtained with G&K and RDWI 
(Table 3). There were 75% subjects with combination 
of hemoglobinopathy and iron deficiency that could be 
accurately identified by RBC or G&K using our cut-off 
(Table 4). In subjects that we classified as could not be 
excluded for alpha thalassemia trait, there was a possibility 
of alpha thalassemia trait of 3.3-83.3% based on erythrocyte 
index and its calculation (Table 5).
Cut-off Sensitivity(%)
Specificity 
(%) Cut-off
Sensitivity
(%)
Specificity 
(%)
RBC 5.0 79.0 90.0 4.7 84.0 81.0
RDW 14.0 12.0 87.0 16.5 63.0 59.0
Mentzer index 13.0 71.0 87.0 13.7 79.0 83.0
RDWI 220.0 85.0 95.0 228.0 88.0 92.0
S&L 1530.0 98.0 8.0 954.0 55.0 56.0
G&K 65.0 80.0 97.0 73.0 90.0 92.0
Literature Current Study
Erythrocyte indices
AUC
(%) p 95% CI
AUC
(%) p 95% CI
RBC 84.8 0.0 78.5–91.1 82.6 0.0 75.6–89.5
RDW 49.6 0.9 40.5–58,7 61.0 0.0  52.1–70.0
Mentzer index 79.3 0.0 72.2–86.4 80.9 0.0 73.8–88.0
RDWI 90.2 0.0 85.1–95.3 90.1 0.0 84.8–95.4
S&L 53.0 0.5 43.8–62.2 55.5 0.2 46.4–64.6
G&K 88.5 0.0 83.1–93.9 91.1 0.0 85.9–96.2
Erythrocyte indices
Literature Current Study
Table 3. Percentage accuration to predict hemoglobinopathy obtained from literature and current study. 
Table 2. The cut-off of erythrocytes indices and its sensitivity-specificity from literature and current study. 
Discussion
Hemoglobinopathy (thalassemia or variant hemoglobin) 
is a genetic disorder of globin synthesis which is required 
for hemoglobin production. The clinical manifestation of 
hemoglobinopathy is varied, ranges from asymptomatic 
to symptoms that need repeated transfusion. Screening of 
hemoglobinopathy using CBC examination is very useful. 
Erythrocyte index from CBC data and its calculation 
with some formula could predict the possibility of 
beta thalassemia. If the result indicates a possibility of 
hemoglobinopathy, further analysis using other methods, 
such as electrophoresis, HPLC, or DNA analysis should be 
performed to confirm the result. Unfortunately, the cost of 
the test is quite high and the test does not always available 
in routine practice.(3,15,17) 
 This study involved 202 patients from many regions 
in Indonesia who underwent thalassemia screening 
and fulfilled the study's criteria. Most of the subjects 
were female (74.3%). The most common etiology of 
microcytic hypochromic erythrocytes in this study was 
hemoglobinopathy (50%); the others were iron deficiency 
(31.2%), combination of hemoglobinopathy and iron 
deficiency (4%) and 14.9% cases could not be excluded for 
alpha thalassemia trait (Table 1). Another study that involved 
901 patients who had microcytic hypochromic erythrocyte 
and underwent thalassemia screening showed nearly similar 
result with ours, 49.2% subjects had beta thalassemia, and 
the rest were due to iron deficiency or other causes.(18)
 Thalassemia patients usually show microcytic 
hypochromic erythrocytes with high RBC.(17) This study 
also showed a high median value of RBC (5.6 millions/
µL). All erythrocyte indices showed significant differences 
between iron deficiency and hemoglobinopathy subjects, 
except MCH (Figure 1). The RBC and hemoglobin 
concentration were significantly higher, but the MCV 
and RDW were significantly lower in hemoglobinopathy 
compared to iron deficiency (hemoglobinopathy vs. iron 
deficiency: RBC = 5.6 vs. 4.4, Hb = 11.8 vs. 9.3, MCV = 
65.9 vs. 69.2, RDW = 15.7 vs. 17.2). This might be due 
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Hemoglobinopathy & Iron Deficiency
 (n = 8) (%)
RBC 75.0
RDW 37.5
Mentzer index 62.5
RDWI 62.5
S&L 62.5
G&K 75.0
Alpha Thalassemia Trait Could Not Be Excluded 
(n = 30) (%)
RBC 70.0
RDW 83.3
Mentzer index 23.3
RDWI 63.3
S&L 3.3
G&K 70.0
Table 4. The percentage of correct prediction of hemoglobinopathy in 
subjects with combination of hemoglobinopathy and iron deficiency. 
Table 5. The percentage possibility of alpha thalassemia trait.
to in hemoglobinopathy the disorder happened only in 
hemoglobin synthesis, not in erythrocytes synthesis, but in 
iron deficiency, the disorder happened both in erythrocyte 
and hemoglobin synthesis.
 Subjects with a combination of hemoglobinopathy 
and iron deficiency showed higher RBC and hemoglobin 
concentration compared to subjects with pure iron 
deficiency, but the MCV and RDW did not show a 
significant difference between  both  groups  (combination 
of  hemoglobinopathy and iron deficiency vs. iron 
deficiency: RBC = 5.03 vs. 4.41, Hb = 10.7 vs. 9.3). But, 
the RBC and hemoglobin concentration within subjects 
with pure hemoglobinopathy (no  combination  with  iron 
deficiency) were higher compared to  those  in  subjects 
with combination of hemoglobinopathy and iron deficiency 
(Figure 1). It was suggested that the presence of iron 
deficiency in hemoglobinopathy patients influenced the 
RBC and hemoglobin concentration that yield a lower result 
compared to pure hemoglobinopathy.
 Erythrocyte indices and their calculation could help 
to screen the diagnosis of thalassemia, especially beta 
thalassemia.(10) Thalassemia mutation spectrum in each 
population are not similar, so that the erythrocyte indices 
will be different among populations. Therefore, a cut-off 
in one population should be determined to increase the 
sensitivity and specificity of thalassemia.(12-15) In this 
study, we analyzed 164 data to determine the cut-off using 
ROC curve. There were different results in sensitivity and 
specificity between literature cut-off and this study cut-off 
(Table 2). Bordbar studied about this in Iran population who 
asked for premarital screening. The study showed that the 
new cut-off did not yield 100% sensitivity and the highest 
sensitivity as 87.6% was shown by S&L.(19) 
 This study showed higher sensitivity was obtained 
if we used our cut-off than literature cut-off, except 
for S&L. The highest sensitivity and specificity were 
obtained by G&K (sensitivity 90.0%, specificity 92.0%) 
and RDWI (sensitivity 88.0%, specificity 92.0%) (Table 
2). Miri-Monghaddam determined their own cut-off in 
Iran population, and that study showed that G&K index 
showed the highest sensitivity (84%) and specificity 
(84%) to differentiate iron deficiency anemia and beta trait 
thalassemia.(13) 
 In this study, the highest accuracy was obtained by 
G&K index and RDWI, 91.1% and 90.9% respectively 
(Table 3). A study by Miri-Monghaddam showed that the 
highest accuracy of hemoglobinopathy was obtained by 
G&K index (AUC 90.9%)(13), whereas Niazi's study 
showed that the highest accuracy was obtained by RDWI 
(AUC 88.4 %).(20) 
 In this study, there were 10 of 101 subjects (9.9%) 
diagnosed as hemoglobinopathy but could not be detected 
using G&K or RDWI. These 10 subjects consisted of 5 
subjects with beta thalassemia trait, 3 subjects with HbH 
disease, and 2 subjects with beta-thalassemia/HbE double 
heterozygote. There were 2 subjects with beta-thalassemia/
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HbE double heterozygote in this study, but both subjects 
could not be detected have a hemoglobinopathy with all 
formula that we studied, except S&L. There were 3 of 6 
subjects of all HbH disease subjects that could be detected 
by RDWI or G&K, but a greater number of these subjects 
could be detected by RBC (83.3%). There were 2 other 
subjects that could not be detected have a hemoglobinopathy 
using RDWI, 1 HbE trait subject and 1 beta thalassemia trait 
subject. 
 There were 75% subjects with combination of 
hemoglobinopathy and iron deficiency that could be 
correctly predicted having a hemoglobinopathy using 
RBC count and G&K index (Table 4). Urrechaga found 
there were 19.5% of subjects with combination of 
hemoglobinopathy and iron deficiency that could not be 
detected have a hemoglobinopathy and were classified as 
iron deficiency anemia. It would be more difficult to detect 
hemoglobinopathy by erythrocyte indices calculation if iron 
deficiency was also present.(21) It might be due to lower 
RBC count and hemoglobin concentration which were 
found if iron deficiency was present with hemoglobinopathy 
as explained above would influence the result of the 
calculation.
 There were 30 subjects that could not be excluded 
for the possibility of alfa trait thalassemia. This was 
classified based  on  undetectable  HbH inclusion body and 
normal/high  ferritin  level  in  subjects  with  microcytic 
hypochromic anemia and normal/slightly low HbA2. HbH 
inclusion body is important marker to help the diagnosis 
of alpha thalassemia. In some cases, HbH might not be 
detected. In one alpha gene deletion (-α/αα) or two gene 
deletion trans type (-α/-α) HbH is more difficult to be found 
and the MCV or the RBC usually show a closer value to 
the reference range compared to two alpha gene deletion 
cis type (--/αα).(22) Using our cut-off, there were still 
3.33-83.3%  possibilities of  having alpha trait thalassemia 
in group of  subjects  with  alpha  thalassemia could not 
be excluded (Table 5). To confirm this, DNA analysis is 
required.  
This study concluded RDWI and G&K with our own 
cut-off, 228 and 73, respectively, showed the highest 
accuracy, sensitiviy and specificity for hemoglobinopathy 
screening in Indonesia. The presence of iron deficiency 
in hemoglobinopathy could decrease the sensitivity of 
Conclusion
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